Three relapses of 2 patients (LA#7 and LA#13)
| Patient No. . | Line . | FVIII at diagnosis (IU/dL) . | BU at diagnosis . | CyDRi (no. of cycles) . | TTBC (d) . | Days on bypass . | TTCR (d) . | CR duration (d) . |
|---|---|---|---|---|---|---|---|---|
| LA#7 | 1 | 5 | 8.5 | 1 | 45 | 45 | 92 | 357 |
| LA#7 | 2 | 11 | NA | 1 | 0 | 0 | 22 | 1385 |
| LA#7 | 3 | 10 | 0.9 | 1 | 0 | 0 | 99 | 1372 |
| LA#13 | 1 | 1 | 140 | 2 | 8 | 3 | 67 | 160 |
| LA#13 | 2 | 19 | 0 | 1 | 0 | 0 | 28 | 161 |
| Patient No. . | Line . | FVIII at diagnosis (IU/dL) . | BU at diagnosis . | CyDRi (no. of cycles) . | TTBC (d) . | Days on bypass . | TTCR (d) . | CR duration (d) . |
|---|---|---|---|---|---|---|---|---|
| LA#7 | 1 | 5 | 8.5 | 1 | 45 | 45 | 92 | 357 |
| LA#7 | 2 | 11 | NA | 1 | 0 | 0 | 22 | 1385 |
| LA#7 | 3 | 10 | 0.9 | 1 | 0 | 0 | 99 | 1372 |
| LA#13 | 1 | 1 | 140 | 2 | 8 | 3 | 67 | 160 |
| LA#13 | 2 | 19 | 0 | 1 | 0 | 0 | 28 | 161 |
TTBC, time to bleeding control.